» Articles » PMID: 29487854

Re-sensitizing Multidrug Resistant Bacteria to Antibiotics by Targeting Bacterial Response Regulators: Characterization and Comparison of Interactions Between 2-Aminoimidazoles and the Response Regulators BfmR from and QseB from Spp

Overview
Specialty Biology
Date 2018 Mar 1
PMID 29487854
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

2-aminoimidazole (2-AI) compounds inhibit the formation of bacterial biofilms, disperse preformed biofilms, and re-sensitize multidrug resistant bacteria to antibiotics. 2-AIs have previously been shown to interact with bacterial response regulators, but the mechanism of interaction is still unknown. Response regulators are one part of two-component systems (TCS). TCSs allow cells to respond to changes in their environment, and are used to trigger quorum sensing, virulence factors, and antibiotic resistance. Drugs that target the TCS signaling process can inhibit pathogenic behavior, making this a potent new therapeutic approach that has not yet been fully exploited. We previously laid the groundwork for the interaction of the response regulator BfmR with an early 2-AI derivative. Here, we further investigate the response regulator/2-AI interaction and look at a wider library of 2-AI compounds. By combining molecular modeling with biochemical and cellular studies, we expand on a potential mechanism for interaction between response regulators and 2-AIs. We also establish that , encoding for only three known response regulators, can be a model system to study the interaction between 2-AIs and response regulators. We show that knowledge gained from studying can be applied to the more complex system, which contains over 50 response regulators. Understanding the impact of 2-AIs on response regulators and their mechanism of interaction will lead to the development of more potent compounds that will serve as adjuvant therapies to broad-range antibiotics.

Citing Articles

Discovery of novel BfmR inhibitors restoring carbapenem susceptibility against carbapenem-resistant by structure-based virtual screening and biological evaluation.

Yao Y, Lei T, Gao J, Xu Q, Xu L, Zhao B Emerg Microbes Infect. 2024; 13(1):2396877.

PMID: 39193648 PMC: 11385636. DOI: 10.1080/22221751.2024.2396877.


Gut Microbial Adaptation to Varied Altitudes and Temperatures in Tibetan Plateau Yaks.

Zhu Y, Wang J, Cidan Y, Wang H, Li K, Basang W Microorganisms. 2024; 12(7).

PMID: 39065118 PMC: 11278572. DOI: 10.3390/microorganisms12071350.


Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants.

Crotteau A, Hubble V, Marrujo S, Mattingly A, Melander R, Melander C Antibiotics (Basel). 2023; 12(11).

PMID: 37998765 PMC: 10668796. DOI: 10.3390/antibiotics12111563.


Adjuvant antimicrobial activity and resensitization efficacy of geraniol in combination with antibiotics on Acinetobacter baumannii clinical isolates.

Kim C, Jin Ko Y, Lee S, Jang S PLoS One. 2022; 17(7):e0271516.

PMID: 35862390 PMC: 9302793. DOI: 10.1371/journal.pone.0271516.


2-Aminoimidazoles Inhibit Biofilms in a Zinc-Dependent Manner.

Belardinelli J, Li W, Martin K, Zeiler M, Lian E, Avanzi C Int J Mol Sci. 2022; 23(6).

PMID: 35328372 PMC: 8951752. DOI: 10.3390/ijms23062950.


References
1.
Imperi F, Antunes L, Blom J, Villa L, Iacono M, Visca P . The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life. 2011; 63(12):1068-74. DOI: 10.1002/iub.531. View

2.
Percival S, Hill K, Malic S, Thomas D, Williams D . Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen. 2011; 19(1):1-9. DOI: 10.1111/j.1524-475X.2010.00651.x. View

3.
Friesner R, Murphy R, Repasky M, Frye L, Greenwood J, Halgren T . Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006; 49(21):6177-96. DOI: 10.1021/jm051256o. View

4.
Liou M, Soo P, Ling S, Kuo H, Tang C, Chang K . The sensor kinase BfmS mediates virulence in Acinetobacter baumannii. J Microbiol Immunol Infect. 2013; 47(4):275-81. DOI: 10.1016/j.jmii.2012.12.004. View

5.
Melander R, Melander C . The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?. ACS Infect Dis. 2017; 3(8):559-563. PMC: 5798239. DOI: 10.1021/acsinfecdis.7b00071. View